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CHAPTER I 
INTRODUCTION 
Many studies have implicated gangliosides as playing an 
important role in the nervous system (Wiegandt, H., 1982). 
Nerve growth and differentiation are affected by gangliosides. 
Neuritogenesis occurs when gangliosides are added to neuronal 
tissue cultures (Ledeen, R., 1984). Neurite initiation, 
elongation, and branching differ in -their response to 
different gangl iosides. The possibility of using gangl iosides 
.. 
for neuronal regeneration is being actively studied. During 
development of the nervous system ther~ are changes in the 
concentration and type of gangliosides present which seem to 
correspond to changes in neuronal differentiation and 
synaptogenesis (Yates, A., 1986). 
The location of gangliosides in the outer leaflet of the 
plasma membrane has led to several studies on the role that 
gangliosides may have in cellular interaction and recognition 
(Hakomori, s. 1981). The gangliosides may be important for 
cell adhesion, contact inhibition, and spreading or as markers 
for as yet unidentified functions. Oncogenic transformation 
has been found to be associated with ganglioside changes and 
may be involved in cell cycle signaling. Several gangliosides 
are thought to act as immune recognition factors and may in 
fact be surface antigens. 
Gangliosides have been claimed to be important receptors 
for several classes of compounds. Initial studies which 
implicated gangl iosides as possible receptors were the binding 
2 
of cholera toxin and tetanus toxin to specific gangliosides. 
Thyroid stimulating hormone, interferon, and neurotransmitters 
(eg. serotonin) have specificities for various gangliosides. 
Sendai virus interacts with gangliosides. Gangliosides may 
not be the actual receptor for many of these biol og i ca 1 
factors but may regulate the actual receptor indirectly. It 
is not surprising that gangliosides may be involved in so many 
different functions because of the wide variety of ganglio-
sides found in nature. This variety is made.possible because 
of the many potential variations in linkages, arrangement of 
sugars, and type of ceramide moiety in gangliosides. The 
spec 1 f i city and the number of enzymes needed to accomp 1 i sh 
this wide variety of ganglioside structures is intriguing 
since each addition of sugar is thought to require its own 
specific glycosyltransferase. In the intact neuron, ganglio-
sides appear to be synthesized at the luminal surface of the 
Golgi cisternae and are then transported to the plasma 
membrane of the neuron via axonal transport. Gangliosides 
have been identified in all mammalian tissues but are found in 
highest concentration in the nervous system. The types of 
gangliosides in each tissue varies and may relate to a tissue 
specific function. Interestingly, gangliosides in the neuron 
are 1 oca 1 i zed in the synaptic p 1 asma membrane and may be 
important for electrical excitabi 1 ity of the membrane and 
synaptic transmission (Leskawa and Rosenberg, 1981). Control 
of the synaptic ionic environment may involve gangliosides 
3 
since it is known that gangliosides bind calcium close to the 
plasma membrane. Another speculative function of gangliosides 
involves their possible role in memory. 
There has been no definitive function attributed exclus-
ively to gangliosides despite the evidence presented above. 
One method of determining the function of gangliosides is to 
study their metabolism in detail and try to verify what 
controls their biosynthesis. Most studies on the metabolism 
of gangl iosides to date have focused on .. identifying the 
metabolic steps through in vitro studies on homogenates but 
gives us no information on how they 'are metabolized and 
compartmentalized in vivo. Initial studies on C6 and N18 cell 
lines provided some evidence of the intracellular processing 
of gangliosides (Fishman and Prodraza, 1982 and 1984). 
Anabolic studies in fibroblasts provided key information on 
how glycosphingolipids are metabolized (Saito, M., et . .§.1. 
1985). These studies on C6, N18, and fibroblasts utilized a 
cationophore called monensin which has been found to specif-
ically inhibit Golgi processing events. The treatment of C6 
and N18 cells with monensin caused a quantitative increase in 
glucosylceramide and a decrease in lactosylceramide, other 
neutral glycol ipids, and gangl iosides. Treatment of 
fibroblasts with monensin resulted in an increase in quantity 
of both glucosylceramide and lactosylceramide and an increase 
in metabolic incorporation of [3HJ-galactose but a decrease in 
labeling of gangliosides. Many of the gangliosides found in 
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normal nervous tissue are not present in these cell lines and 
because these cell lines are transformed they may have altered 
biosynthetic and transport pathways. Primary neuronal 
cultures exhibit the polysialogangliosides present in normal 
tissue but absent in the cell lines and also are not trans-
formed. Therefore the primary neuron should provide a better 
model for studying the processing pathways of gangliosides. 
The initial, central, and terminal glycosylations of the 
complex glycosphingolipids can be studied by using the mono-
valent cationophore monensin as a tool for disruption of the 
Golgi complex. The organization of the Golgi cisternae is 
thought to involve close interactions with the cytoskeleton. 
Inhibitors of the cytoskeleton can also provide a tool for 
studying. glycosphingolipid metabolism. Colchicine, which 
causes depolymerization of the microtubules; vinblastine, 
which causes crystallization of microtubules; and cytochalasin 
D, which inhibits actin polymerization in microfilaments will 
be used to study the metabolism of gangliosides. Cobalt is 
also thought to interfere with intracellular transport events 
by inhibiting fusion of transitional elements with the Golgi 
complex and by inhibiting transport of vesicles exiting the 
Golgi and can be used as a specific tool for glycosphingolipid 
metabolism. Since calcium plays such a fundamental role in 
transport events and in cytoskeletal assembly the use of the 
calcium ionophore A23187 to perturb the intracellular calcium 
concentration will also be useful in this study. The various 
5 
inhibitors mentioned above shall be used on primary neuronal 
cultures to determine what role intracellular transport 
processes play in the metabolism of glycosphingolipids and to 
further understand the possible function of these interesting 
molecules. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Gangliosides 
Structure and Metabolism 
The structure and chemical characterization of 
gangliosides has been extensively studied (for review see Li 
and Li, 1982 and Wiegandt, 1982). Gangl i os ides are amp ho-
philic in nature and consist of a lipophilic ceramide moiety 
and a hydrophilic carbohydrate moiety. The ceramide moiety is 
inserted into the outer leaflet of the plasma membrane and the 
carbohydrate moiety extends outward into the aqueous phase. 
Biological prop~rties of gangliosides are closely associated 
with the carbohydrate moiety but the ceramide moiety is also 
important in orienting the oligosaccharide chain and allowing 
movement in the fluid phase of the plasma membrane. 
Biosynthesis of ceramide is presented in Figure 1. 
Palmitoyl-CoA reacts with a pyridoxal-P-bound serine to form 
3-ketodihydrosphingosine which results in the decarboxylation 
of serine. The 3-ketodihydrosphingosine is then reduced with 
NADPH to form dihydrosphingosine. A double bond is formed 
when a flavoprotein enzyme dehydrogenates dihydrosphingosine 
to sphingosine. The sphingosine residues of vertebrate 
nervous system gangliosides have predominantly 18 and 20 
6 
7 
carbon atoms which depends on the in it i a 1 acy 1-CoA which 
condensed with serine. Ratios of C18-sphingosine and 
C20-sphingosine vary with age, localization, and ganglioside 
type (Avrova and Zabel insky, 1971; Yohe et al., 1976). 
Sphingosine is acylated at the amino group with another 
acyl-CoA of a long chain fatty acid to form:ceramide. This 
fatty acid can also vary according to ag~, localization, and 
ganglioside type but the predominant type (>80%) in mammalian 
brain gangliosides is stearic acid. 
The carbohydrate moiety of gangliosides is attached to 
the primary hydroxyl of ceramide in straight or branched 
chains through glycosidic bonds. The most common sugars found 
in gang l i os ides are g 1 ucose, gal actose, N-acety l gal actosami ne, 
and N-acetylneuraminic acid (i.e. sialic acid). Nomenclature 
of gangliosides is based upon the chemical structure of the 
carbohydrate moiety. One of the most common systems of naming 
is that of Svennerholm, 1963. The capital letter "G" symbol-
; zes gangl iosides and the capital letters "M", "D", "T", and 
"Q" represent mono, di, tri, and quatro sial ic acid residues, 
respectively. A "1" refers to the four residue backbone 
Ga 1-Ga l Nae-Ga 1-G l c, the number "2" designates the 3 residue 
backbone GalNac-Gal-Glc, and the number "3" represents the 2 
residue backbone Gal-Glc. The "a" and "b" notation refers to 
the position of the sialic acid residues when necessary. GD1a 
and GD1b both have two sialic acid residues but the residues 
are in a different configuration on each. An "a" or "b" 
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designation is given if there is one or two sialic acid(s) 
attached to the proximal galactose, respectively (the 
galactose closest to ceramide is referred to as the proximal 
galactose and the galactose farthest away is called the distal 
galactose). 
Biosynthesis of gangliosides is repres~nted in Figure 2 
(for review see Fishman and Brady, 1976 and Wiegandt, 1982). 
Specific glycosyltransferases catalyze the transfer of sugars 
from activated sugar donors to ceramide o~-a growing oligo-
saccharide chain. The activated sugar substrates are UDP-
glucose, UDP-galactose, UDP-N-acetylgalactosamine, and CMP-
sialic acid. These glycosyltransferases show a high degree of 
specificity for the sugar and lipid substrates. Glucosyl-
transferase catalyzes the transfer of glucose from UDP-glucose 
to ceramide to form glucosylceramide (Basu et al., 1968 and 
1973). The formation of lactosylceramide (LacCer) from UDP-
galactose and GlcCer by lactosyltransferase has been shown 
( Basu et a 1 . , 1968). LacCer: s i a 1 y 1 transferase has been 
demonstrated to catalyze the transfer of sialic acid from 
CMP-sialic acid to lactosylceramide to form the ganglioside 
GM3 (for review see Samuelsson, 1987). Sialic acid is bound 
only to galactose or to another sial ic acid residue. The 
addition of one or more sialic acid(s) distinguishes ganglio-
sides from other glycosphingol 1pids. The biosynthetic pathway 
bifurcates at GM3 to follow two distinct proposed routes (the 
"a" series and the "b" series). GM3 is converted to GM2 by 
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N-acetylgalactosaminyltransferase which transfers a N-acetyl-
galactosamine from UDP-N-acetylgalactosamine (Steigerw~ld et 
al., 1975). N-acetylgalactosaminyltranferase is thought to 
regulate the synthesis of the more complex gangliosides 
(Fishman and Brady, 1976). GM1 can be formed from GM2 by the 
transfer of a galactose from UDP-galactosEt by a galacto-
syl transferase ( Basu et a 1. , 1965). The formation of GD1 a 
from GM1 requires the transfer of a sialic acid from 
CMP-sial ic to GM1 by a sialyltransferase ·i-Kaufman et al., 
1968). The formation of the trisialogangl ioside GT1a from 
GD1a is catalyzed by a sialotransferase which transfers a 
sialic acid from CMP-sialic to give a disialo residue on the 
termi na 1 ga 1 actose (Yohe, 1980) . Synthesis of GD3 which 
begins the "b" series has been demonstrated (Kaufman, 1968). 
A sialyltransferase catalyzes the transfer of sialic acid from 
CMP-sialic acid to GM3 to form GD3. A GalNac (from UDP-
GalNac) is then added to GD3 by a N-acetylgalactoseaminyl-
transferase to produce GD2 (Cumar et al., 1971). Synthesis of 
GD1b from GD2 and UDP-Gal by a galactosyltransferase has been 
described (Cumar et al., 1972). The structure of GM3 is given 
in Figure 3 to show the most common linkages found in ganglio-
sides. Linkages shown in Figure 3 indicate that sialic acid 
is often found in an a glycosidic bond (several other linkages 
are known to exist) and the other sugars are usually in a a 
glycosidic bond. The linkage designation for the four sugar 
backbone found in several of the gangliosides is Gal(B1-3)-
10 
Ga1Nac(131 .... 4)Gal(l31 .... 4)Glc(131 .... )Cer. When sialic acid is bound 
to a galactose the linkage is (a2 .... 3) and when bound to another 
sialic acid is often a (a2 .... 8) linkage but other linkages do 
exist. The transfer of sialic acid from CMP-sialic acid to 
GD1b to form GT1b is catalyzed by a sialyltransferase 
(Mestral let et al., 1977). A tetrasialogangl ipside, GQ1b, can 
be synthesized from GT1b and CMP-sialic acid by another 
sialyltransferase (Yohe et al., 1982). Higher polysialo-
gangliosides have been identified but ~their enzymatic 
synthesis has not been demonstrated. An ordered precursor-
product relationship provides good evidence for the pathway 
shown in Figure 2. There has been some specu lat 1 on that 
multiglycosyltranferase complexes may exist (Roseman, (1970) 
and Landa et. A]_. (1977). These multienzyme complexes would 
contain two or more transferases and the final product would 
be released after the initial substrate was acted upon by each 
of the transferases in sequence. There has been some specula-
tion that each gang 1 i os i de would require a separate mu 1 t ;-
enzyme complex. Anabolism of gangliosides is thought to 
primarily reside in the Golgi complex (Yusuf et. ~l- (1984) 
and Landa et. A]_. (1979)) because studies have determined that 
several of these glycosyltransferases are primarily localized 
in the Go lg i complex ( Keenan , T. W. , ~t. a 1. ( 1 9 7 4) ; 
Wilkinson, F.E. et. Al, (1976); Richardson, C. L., ~t. al. 
(1977); Eppler C.M., (1980); and Senn H.J. (1981 and 1983). 
Most of these glycosyltransferase studies were done on sub-
1 1 
fractionations of rat liver (because of the difficulty of 
obtaining a Golgi subfraction from brain) so it is debatable 
if these results equate to the nervous system. 
There is also evidence for ganglioside enzyme activ-
ities (sialidase-sialosyltransferase) in the outer leaflet of 
the plasma membrane that function to modify e~isting ganglio-
sides (Schengrund C.L. and Rosenberg, A. (1970); Leskawa, K. 
and Rosenberg, A. (1981); Preti, A (1980). These surface 
enzymes could regulate the local environment.-and alter various 
synaptic events. 
Degradation of gangliosides also occurs systematically 
(Tettamanti, 1984). Each sugar moiety is removed from the 
non-reducing terminus of the ganglioside by specific glyco-
hydrolases starting with the terminal sugar. Ceramidase can 
then cleave ceramide to form sphingosine and fatty acid. 
These degradative enzymes are localized in the plasma membrane 
and in lysosomes. Interest in these degradative enzymes was 
driven by the fact that several diseases have been identified 
which result from a deficiency (loss of activity) of a part-
icular glycohydrolase (Wiegandt, (1982); Kanfer, J.N. (1983)). 
Gaucher disease is autosoma l recessive and is caused by a 
structural mutation of the lysosomal enzyme glucosylceramide 
(3-glucosidase. This defect results in an accumulation of 
glucosylceramide in particular organs and can cause severe 
pathological changes. Tay-Sachs disease results from the 
inabi 1 ity to cleave N-acetyl-galactosamine from GM2 because of 
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a deficiency in hexosaminidase. Several other enzyme defic-
iencies have also been discovered which involves a loss of 
lysosomal degradative activities and can lead to neurological 
damage. 
One exception to this is an identified loss of 
activity in an anabolic enzyme which resulteq in the death of 
the patient. This anabolic enzyme is UDP-GalNac : GM3 N-
acetylgalactosaminyl transferase which produces GM2 from GM3. 
The patient lost all higher gangliosides anG only GM3 and GD3 
were detectable. This GM3 gangliosidosis is the reverse of 
Tay-Sachs disease. The severe problems which can result from 
these changes in activities imply an important function for 
gangliosides. 
Gangliosides exhibit distribution patterns which are 
species and tissue specific (Nagi and Iwamori, 1984). 
Gangl iosides occur in all mammalian tissues studied. The 
greatest degree of complexity and the highest concentration of 
gangliosides is seen in the nervous system (particularly the 
gray matter) which suggests an important physiological role. 
There are also regional differences in ganglioside patterns 
found in the brain (Yates, 1986). In neurons there are higher 
concentrations of gangliosides found in the synaptosomal frac-
tions than in the perikarya (Morgan, et . .§1. (1976); Burton, 
(1976); and Leskawa and Rosenberg, (1981)). 
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Changes occur in the gangl ioside pattern during nervous 
system development in chick, rat, mouse, and human (Dreyfus, 
et. A}_. 1980 and Yates, 1986). These changes in ganglioside 
pattern appear to correspond to changes in eel 1 division, 
synaptogenesis, myelination, and neuronal differentiation. In 
human and rat there is a significant increas~ in ganglioside 
content and there are changes in ganglioside pattern during 
development. Chick primary neurons display all the ganglio-
sides associated with adult nervous system tissue. There is a 
large increase in ganglioside concentration and a significant 
changes in the ganglioside pattern during cell maturation of 
chick primary neurons. GD3 is the major ganglioside in chick 
primary cultures during cell division (days 1-3) but decreases 
during synapse formation and differentiation (days 3 and 4) 
while GD1a increases during synapse formation. This change in 
the ratio of GD3 to GD1a also is found during development of 
the retina and brain hemispheres (Dreyfus,~~- al. 1975). The 
similarities between primary neuronal and whole tissue onto-
genesis suggest that primary neurons would serve as a good 
model for the study of ganglioside metabolism. 
Neuronal differentiation, contact interactions, trophic 
properties, and neuritogenesis coincide with changes in the 
distribution pattern and/or complexity of gangliosides 
(Ledeen, 1984 and Dreyfus, 1978). Gangliosides have been 
reported to cause neur i togenes is when added exogenously in 
neuronal cell lines and in primary neurons (Leskawa and Hogan, 
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1985 and Byrne, et. u. 1983). PC 12 ce 1 ls have increased 
neuritogenesis after gangl ioside addition but only in the 
presence of nerve growth factor suggesting a modulation affect 
on neurotrophic factors (Matta, 1986). The possibility of 
using gangliosides as regenerative agents for nervous system 
lesions is being actively pursued. Neurite initiation, 
growth, branching, adhesion, target recognition, and synap-
togenesis may each or may all be involved in the effect of 
gangliosides on neuritogenesis. 
Many biological molecules have been found to interact 
with gangliosides at the cell surface. The initial discovery 
of the ability of gangliosides to bind various molecules at 
the cell surface was the binding of cholera toxin to GM1 (Van 
Heyningen, 1974). Tetanus toxin was also found to bind gang-
lioside (Van Heyningen, 1976). Since gangliosides do not 
normally bind toxins there has been an extensive search for 
other physiological important molecules which bind ganglio-
sides. Many such molecules have been discovered (Wiegandt, 
1982). Thyroid stimulating hormone (TSH) was one of the first 
effector molecules found to bind gangliosides (Mullin, 1976). 
The binding of TSH to membranes was inhibited by the addition 
of gangl iosides. Interferon also can bind to gangl ioside 
(Besancon and Ankel, 1974). Gangliosides also act as a 
possible receptor for serotonin (Ochoa and Bangham, 1976). 
Many other biologically significant molecules have been ident-
ified as binding to gangliosides suggesting the diverse roles 
that gangliosides may have at the cell surface. 
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There may 
also be a modulation effect of gangliosides on surface enzyme 
activities. GQ1b has been shown to stimulate the activity of 
ecto-protein kinase (Tsuji, 1988). Several of the glycosphin-
golipids have been identified as possible cell surface anti-
genic determinants and so may be important for immune recog-
nition (Hakomori, 1981). 
gangliosides. 
Anti bodies can be ra i sad against 
There is growing evidence to supJ!)Ort the role of 
gang 1 i os ides in the bi ochemi ca 1 events mentioned above but 
their actual in situ biological role is unknown. Much of the 
difficulty in establishing a role for gangliosides in the 
nervous system is the heterogeneous cell population present. 
One approach to the problem has been to produce clonal cell 
lines derived from the nervous system which provides a homo-
geneous cell population and are easy to propagate. It has 
been suggested that transformed clonal cell lines may not be 
adequate for studying ganglioside metabolism because of the 
deficiency of polysialogangliosides and that primary neuronal 
cultures possess gangliosides patterns which closely resemble 
tissue cell fractions (Dreyfus et,. Af., 1978). Transformed 
cells are devoid of normal growth restraints and are missing 
the more comp 1 ex gang 1 i os ides (Fishman and Brady, 19 7 6) . 
These higher gangliosides may be important for cell contact 
inhibitions and transformation may be a direct result of their 
loss. 
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Very little is known concerning the intracellular 
ganglioside biosynthetic pathways and their relations~ip to 
the Golgi apparatus in the nervous system and primary neuronal 
cells will provide an excellent model for studying these 
complex events. Knowledge of neuronal biosynthesis of gang-
liosides .in vivo is limited because of the he~erogeneous cell 
population and the difficulty in isolating Golgi from lipid 
rich cells ( Yusuf et. Al, 1978). Most studies on anabolism 
have come from in vitro studies on brain microsomes, liver 
subfractionations, and purified enzyme preparations (for 
review see Wiegandt 1982). The information obtained from in 
vitro studies has given us a good understanding of the steps 
involved in ganglioside biosynthesis. Studies in vivo are 
essential to provide us with a clearer picture of ganglioside 
metabolism and may provide clues as to the function of 
gangliosides. 
Monensin is a carboxylic polyether monovalent 
cationophore which has been shown to specifically inhibit 
intracellular transport of several classes of proteins which 
are processed through the Golgi complex (apparatus) (Tartakoff 
, 1983a and 1983b). In biological membranes monensin acts as 
a diffusional carrier which mediates a cation exchange and 
results in an equilibration of the ionic environment. It is 
lipophilic and can presumably insert into membranes. Treat-
ment of cells with monensin results in a rapid dilation of the 
Golgi cisternae and there is no apparent affect on other 
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intracellular organelles. The endoplasmic reticulum and the 
transitional elements which are in close association with the 
Golgi are unaffected. Nothing is known of the ion content of 
the Golgi so it is difficult to explain why monensin has this 
unique effect. Tartakoff (1983a) gJves two possible 
explanations on how the swelling may occur. 
1 . The c is te rnae may contain a weak acid and passive 
water influx may occur if protons exchange With Na+. 
2. Ion pumps may control the efflux of water which 
results in the normal compressed form of the cisternae and any 
interference with these pumps will allow them to dilate. 
Overall protein synthesis, ATP levels, and pH are 
unchanged after monensin treatment. The action of monensin 
appears to be a specific inhibitor of Golgi processing events. 
The Golgi subsite of transport inhibition has been postulated 
to be somewhere between the distal and proximal compartments 
of the Golgi complex. Monensin has provided researchers with 
a good tool for exploring the poorly understood area of 
protein processing and transport events of the Golgi. Gang-
liosides are another important class of compounds which are 
processed within the Golgi (Yusuf et. u. 1984). Monensin 
has recent 1 y been used to study its effect on gang 1 i os i de 
biosynthesis in fibroblasts (Saito et. u_. 1984,1985), N18 
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neuroblastomas, and C6 gliomas (Miller - Prodraza and Fishman, 
1984). These studies indicate that initial sites of _glyco-
sylation and final sites are distinct and that some type of 
subcompartmentation exists. Treatment of fibroblasts, N18 
neuroblastomas, and C6 gliomas with monensin results in an 
increase in labeling (with [3HJ-Galactose added to the media) 
and concentration of glucosylceramide. An increase in label-
ing and concentration of lactosylceramide was seen in fibro-
blasts but not in N18 and C6 cultures which·-may indicate eel l 
differences. Other gangliosides and higher neutral glyco-
sphingolipids show a decrease in labeling and no change in 
concentration. Polysialogangliosides are absent from the N18 
neuroblast (Dreyfus et. ~- 1978) and the study of Golgi 
processing events may be a 1 tared in these ce 11 s. Primary 
neuronal ganglioside patterns are similar to tissue patterns 
and therefore may provide a better analysis of ganglioside 
anabolism. 
Microtubules are thought to be important in maintaining 
the organization of the Golgi complex (Thyberg and Moskalew-
ski, 1985) possibly by maintaining the three dimensional 
orientation of the cisternal stacks. Microtubules may inter-
act directly with the cisternae by attachment to microtubule 
associated proteins. Colchicine and vinblastine are two 
microtubule inhibitors which cause disassembly of microtubules 
and a reversible disruption of the Golgi complex. Both of 
these inhibitors caused dilation of the cisternae much like 
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monensin. The depolymerization of microtubules by colchicine 
and the crystallization of microtubules by vinblastine can 
disrupt both Golgi transport and intraneurite transport. 
secretion of sever a 1 compounds ( co 11 agen, growth hormone, 
insulin, lipoproteins, etc.) has been shown to be inhibited by 
colchicine. Since colchicine and vinblastjne act through 
different mechanisms it would be of interest to compare both 
inhibitors for their effect on glycosphingolipid transport 
processes. 
Cytochalasins are inhibitors of actin polymerization 
which interfere with the contractile process of microfilaments 
(Goddett and Frieden, 1986) but are not thought to interfere 
with intracellular transport. The addition of actin subunits 
at the growing end of mi crof il aments is i nhi bi ted. The 
retraction of neurites in PC12 cells is prevented by 
cytochalasin D (Joshi, et. AI- 1985) which actually appears to 
stabilize the neurite. It will be interesting to compare this 
microfilament inhibitor with the microtubule inhibitors 
mentioned above. 
To determine if calcium plays a role in glycosphingo-
lipid metabolism the calcium ionophore A23187 can be utilized. 
A23187 is an antibiotic which can bind divalent cations and 
transport them across membranes (Reed and Lardy, 1972). 
Divalent cations are important in formation of microtubules 
and microfilaments and perturbation of calcium concentrations 
by the ionophore A23187 will disrupt this formation and thus 
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may interfere with Golgi transport and intracellular 
transport. 
Cobalt is a calcium antagonist which has been shown to 
interfere with the initial passage of new proteins from the 
endoplasmic reticulum to the Golgi complex and also to 
interfere with protein transport at a stage a{ter the proteins 
have left the Golgi but before the proteins have entered the 
axon (Stone and Hammerschlag, 1981 and 1987). Sorting and 
vesicular delivery of proteins which are ex4ting the Golgi is 
thought to involve the trans-Golgi network (also referred to 
as GERL: Golgi-Endoplasmic-Reticulum-Lysosome)( Griffiths and 
Simons, 1986). The action of cobalt is thought to be due to 
the inhibition of the calcium mediated fusion of the trans-
itional vesicles with the cis Golgi surface and to inhibit the 
vesicles exiting the Golgi by preventing fusion with transport 
organelles in the trans-Golgi network. Monensin and cobalt 
both interrupt intracellular transport of proteins but at 
different sites. 
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SPECIFIC AIMS 
Ganglioside metabolism in vivo is poorly under~tood. 
There is good evidence that gangl iosides synthetases are 
localized in the Golgi but how these synthetases are arranged 
and in what compartments gang 1 i os ides .are synthesized is 
unknown. The aim of this research is to clarify the complex 
area of ganglioside biosynthetic processing in primary 
neurons. Various inhibitors are known to inhibit Golgi 
processing events. This research wi 11 compare the effects 
that monensin, colchicine, vinblastine, cytochalasin D, A23187 
and cobalt have on neuronal development, Golgi function, and 
ganglioside biosynthesis in cultures of primary neurons. 
Hopefully by examining the in vivo processing of these 
gangliosides not just the biosynthetic pathways will be 
elucidated but a function for gangliosides may also be found. 
CHAPTER III 
MATERIALS AND METHODS 
MATERIALS 
Eggs were obtained from Sharp sales (West Chicago, Il.) 
or Hall Brothers hatchery (Wallingford, Conn.) and were 
incubated at 38. s0c in a humid atmosphere and turned auto-
mat i ca 11 y every 3 hours. Plastic petri di shes, Dul becco' s 
modified Eagles media (DMEM), Fetal Bovine Serum (FBS), 
penicillin (5000 U/ml) - streptomycin (5000.mcg/ml) (PS), and 
phosphate buffered saline (PBS) were obtained from Gibco. 41 
µ nylon mesh ( Spectramesh) and HPLC qua 1 i ty so 1 vents were 
obtained from Fisher Scientific. Insulin 6.~5 µg/ml- trans-
ferrin 6.25 µg/ml- selenium 6.25 ng/ml- bovine serum albumin 
1.25 mg/ml- linoleic acid 5.35 µg/ml (ITS+) was obtained from 
Collaborative Research. Unisil (activated silicic acid 100-
200 mesh) was obtained from Clarkson Chemical Company. 
Dialysis membrane was obtained from Spectrum Medical 
(Spectrapor MW cutoff 12,000-14,000). High performance silica 
gel 60 thin layer chromatography plates (HPTLC-10 X 20 cm) 
were obtained from E. Merck. Bovine brain gangliosides and 
ceramides from bovine brain sphingomyelin were obtained from 
Sigma. Purified GM1, GD1a, and GT1 were obtained from 
Supelco. DL-dihydrolactocerebroside, DL-dihydroglucocere-
broside, and DL-dihydrogalactocerebroside were obtained from 
Calbiochem. Resorcinol and cupric sulfate were obtained from 
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sigma and resorcinol spray was prepared fresh weekly (1.0 ml 
of 6% resorc i no l in water ( was stored at 4°c and protected 
from light)+ 8.0 ml concentrated HCl + 25 µl 0.1 M cupric 
sulfate+ 1.0 ml water. Anthrone and thiourea were obtained 
from Sigma and anthrone spray was prepared fresh weekly (66 ml 
95% sulfuric acid + 34 ml water + 0.5 g anthrone + 10 g 
thiourea (was stored at 4°C and protected from light). P-10 
gas (10% methane and 90% argon was obtained from Matheson Gas. 
Monensin and nigericin were obtained from Ca..lbiochem Behring. 
Colchicine, vinblastine, cytochalasin D, A23187, and cobalt 
(CoC1 2-eH20) were obtained from Sigma. 
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METHODS 
Primary Neuronal Cultures 
Pure primary neurons were prepared from the telenceph-
alon of 7 or 8 day chick embryos (Pettman et. fil..). Plain 
plastic petri dishes were coated with poly-L-lysine by 
treating each dish with sterile filtered poly-L-lysine ( 15 
mg/liter in boric acid 0.1 M pH 8.4 - 10 mt per 100 mm dish) 
and allowed to sit overnight. The polylysine solution was 
removed and each dish was rinsed once {n phosphate buffered 
saline (10 ml per 100 mm dish). DMEM containing 15% FBS and 
2% PS was then added to each dish (9 ml per 100 mm dish) and 
the dish~s were placed in the incubator at 37°c with 5% co2 -
95% air. All tools were sterilized with 70% EtOH and flamed 
before the removal of each embryo from its egg. All eggs were 
cleaned before beginning. All tissue culture work was per-
formed under a laminar flow hood and standard sterilization 
techniques were used. 7 or 8 day old eggs were rinsed with 
70% EtOH and the blunt end was chipped out with sterile 
forceps. The forceps were rester i 1 i zed and the chor i o-
a 11 anto i c membrane was pee 1 ed away. Forceps were again 
sterilized and the embryo was removed by grasping under the 
head. The embryo was gently placed in a 100 mm petri dish 
containing 10 ml DMEM. With sterile forceps the two tele-
ncephalon lobes were dissected out and any attached meninges 
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were removed. The lobes were placed in DMEM - 2% PS. Lobes 
were gently drawn into a 10 ml pipet and the lobes settled 
quickly into the tip and were blown out into 10 ml of media. 
The lobes settled quickly into the bottom of the tube and the 
overlaying media was immediately removed. Lobes were dissoc-
iated by passing them back and forth throu~h the tip of a 
pi pet several times unti 1 they were well dispersed. The 
dissociated cells were passed through a sterile 41 µ nylon 
mesh which was placed over the end of a glass tube (7 cm long 
and 14 mm i nterna 1 diameter) and ster i 1 i zed ( the tube was 
dipped in 70% EtOH, sonicated for 5 minutes and then placed in 
a petri dish under the tissue culture hood to air dry before 
use). The mesh was rinsed with an additional 5 ml media. The 
cells were diluted and counted in a hemacytometer. Cell 
counting and viability was determined by trypan blue exclusion 
(Malinin and Perry, 1967). Cells were added to prewarmed 
media (6 X 106 cells per 100 mm dish). The cultures were 
incubated at 37°c with 5% co2 - 95% air in a humidified 
atmosphere. After 3 or 4 days the media was changed and 
replaced with DMEM - 15% FBS - 2% PS or with defined media 
(DMEM - ITS+ - 2% PS). 
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Glycosphingolipid Isolation 
Glycosphingolipids were extracted and analyzed (Saito 
et. u. 1984 and 1985). All solvents used were of HPLC grade. 
Incubation of the cultures was stopped by placing the dishes 
on ice. The media was then removed and co 1 d phosphate 
buffered saline ( PBS pH 7. 4) was added to each di sh. Ce 11 s 
were gent 1 y scrapped off with a rubber po 1 iceman and were 
pl aced in a 1 3 X 1 00 mm test tube which was._on ice. A second 
al i quot of cold PBS was added to each di sh. The di sh was 
scrapped again to ensure removal of most of the cells and the 
cells were added to the first scraping. Cells were pelleted 
in a refrigerated centrifuge (1500 rpm for 5 minutes) and the 
supernatant was discarded., The cells were twice more resus-
pended and repelleted. The cell pellet was extracted immed-
iately or frozen at -00°c for later analysis. Total lipids 
were isolated from the cells by sequential extractions with 1 
m 1 CHC l 3 - MeOH 2: 1 ( v: v) , 1 m 1 CHC l 3 - MeOH 1 : 2 ( v: v) , and 1 
ml CHCL3 - MeOH 2:1 (v:v). After each addition of solvent the 
cells were sonicated and allowed to sit for 5 minutes and then 
centrifuged at 3000 rpm for 1 0 minutes and the supernatant 
from the three extractions was combined. 
The total lipids and the remaining protein pellet were 
dried (evaporation of the solvent with nitrogen or the Savant 
centrifugal evaporator). The protein pellet was saved for 
protein analysis (Hess et. u. 1978). 
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Total lipids were separated into neutral lipids and 
gangliosides by silicic acid chromatography (Saito §1. ~1-, 
1984 and 1985). Silicic acid columns were prepared by 
placing a small plug of glass wool in a small pasteur pipet 
. and adding silicic acid to a depth of 2 cm. The total lipids 
were dissolved in 1.0 ml CHC1 3-MeOH 2:1 (¥:v), sonicated, 
allowed to sit for 10 minutes, and then applied to the silicic 
acid column. Another 0.5 ml CHC1 3 - MeOH 2:1 (v:v) was added 
to each test tube in order to rinse it a:nd then was a 1 so 
applied to the column. An additional 1.5 ml CHC1 3 - MeOH 2:1 
(v:v) was used to wash the column. The eluant contained the 
neutral 1 ipids. Each column was then placed over a second 
test tube and washed with 2.0 ml CHC1 3 - MeOH - H2o 50:50: 15 
(v:v:v). The eluant, which contained the ganglioside 
fraction, was collected. The neutral 1 ipid and gangl ioside 
fractions were then dried. 
Neutral glycolipids were separated from the neutral 
1 ipids with another si 1 icic acid column (Saito §t. al., 
1984,1985). The neutral lipids were dissolved in 0.5 ml 
CHC1 3, sonicated, allowed to sit 5 minutes, and then layered 
on top of the column. Another 0.5 ml CHC1 3 was used to rinse 
the test tube and this was also applied to the column. The 
co 1 umn was washed with an additional 1 . o ml CHC 13 and the 
eluant was discarded. 3 ml acetone - MeOH 9:1 (v:v) was added 
to the column and this fraction which contains the neutral 
glycolipids was collected and dried. To each dried neutral 
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glycolipid and ganglioside fraction 150 µl H2o was added and 
then sonicated and dialyzed overnight by attaching a dialysis 
membrane over the open end of the test tube and tightly 
fastening it with a rubber band. To dialyze, the tubes were 
inverted and placed in distilled water for 24 hours. The 
dialyzed samples were centrifuged at 1500 rpm for 5 minutes 
and then lyophilized (the dialysis membrane was removed and 
replaced with lens paper). 
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GLYCOSPHINGOLIPID THIN LAYER CHROMATOGRAPHY 
Purified glycosphingolipid fractions were separated by 
high performance thin layer chromatography (HPTLC). Each 
sample or standard was dissolved in 20 _µ1 CHCl 3 - MeOH 2: 1 
(v:v), sonicated, and applied with a glass capillary (was 
prepared by flaming a capillary and drawing it out until a 
very fine tip formed) as a thin streak (1mm thick x 1cm wide) 
1 cm from the bottom of a HPTLC plate. Eac~ sample tube was 
rinsed with another 20 µ1 CHC1 3 - MeOH 2/ 1 (v:v) and this was 
a 1 so app 1 i ed. Gang 1 i os i de standards were app 1 i ed to each 
plate for ganglioside analysis. Neutral glycolipid standards 
were applied to each plate for neutral glycolipid analysis. 
The developing solvent for separation of gangl iosides was 
CHC1 3 - MeOH - 0.25% cac1 2 54:42: 10 (v:v:v) and for neutral 
glycolipids was CHC1 3 - MeOH - H2O 65:25:4 (v:v:v). The TLC 
development tank was equilibrated for at least 2.0 hours with 
50 ml developing solvent (a filter paper saturation pad was 
placed in the tank to provide for a more even equilibration). 
The plates were placed in the tank and the solvent was allowed 
to rise to the top of the plate. The plate was removed and 
air dried. Separated bands were transiently marked with 
iodine vapor to determine position. Gangliosides were more 
permanently stained with resorcinol spray which splits off the 
sialic acid groups and then reacts with sialic acid to give a 
quantitative response. The plate was sprayed with resorcinol. 
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A clean cover glass was then clamped over the HPTLC plate and 
heated at 120°c for 20 minutes (the silica layer was face down 
when heating). Neutral glycolipids were sprayed with anthrone 
reagent and heated at 140°c for 15 minutes to give a quanti-
tat i ve response. Quantitation of the i~dividual bands was 
determined by densitometric scanning. GaAgliosides were 
scanned at 580 nm and neutral glycolipid~ at 625 nm using a 
Kratos model SD 3000 spectrodensitometer attached to an 
Hewlett-Packard model 3390A integrator. ·- Standard linear 
plots were established for the standards (µg standard versus 
area under the densitometric peak) and the amount of unknown 
sample glycosphingolipid was determined from the plot. 
Identification of each individual sample band was determined 
by comparison to the retention time of the purified standards. 
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CERAMIDE ANALYSIS 
Total lipids were isolated as previously stated. The 
lipids were dissolved in CHC1 3 - MeOH 9:1 (v:v), sonicated, 
allowed to sit for 10 minutes, and then applied to a silicic 
acid column (prepared as previously statedL The ceramide 
fraction was then eluted with three washes of 2.0 ml CHC1 3 -
MeOH 9:1 (v:v). Samples were applied to a HPTLC plate along 
with ceramide standards. The samples were developed in CHC1 3 
- MeOH - water 60:35:8 (v:v:v) until the solvent front reached 
4.0 cm from the bottom of the plate (Selvam and Radin, 1981). 
The plate was removed and the solvent was evaporated from the 
plate in a vacuum desiccator for 20 minutes. The plate was 
chromatographed again with CHC1 3 - MeOH - acetic acid 90:2:8 
(v:v:v) until the solvent front was 1.0 cm from the top of the 
plate then the plate was removed. Solvent was evaporated in 
a vacuum des1ccator for 30 minutes. The lipids were visual-
ized by charring the plate with 3% cupric acetate in 8% 
phosphoric acid (w:v) and heating at 1ao0c for 15 minutes 
(Fewster et. u.,1969). Densitometric scanning was done as 
previously stated (350 nm). 
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RADIOACTIVE LABELING OF GLYCOSPHINGOLIPIDS 
Gangliosides and neutral glycolipids were labeled with 
o-[1-3HJ-Galactose (1.0 mCi/1.0 ml ethanol:water 9:1; 11.5 
Ci /mmo 1 e-Ameri can Radio 1 abe 1 ed Chemi ca 1 s). D- [ 1- 14 c ]-N-Acety 1-
mannosami ne (0.1 Mci/1.0 ml ethanol:water 9:J ; 55mCi/mmole-
New Eng 1 and Nuc 1 ear) was a 1 so used to 1 abe l gang 1 i os ides. 
[ 14CJ-Acetate (50 Mei/Mm) (American Radiolabeled Chemicals) was 
used to label ceramide. To each 100 mm dish, 10 µCi of [ 3HJ-
galactose, 1.0 µCi c14c]-N-acetyl-mannosamine, or 10 µCi [ 14cJ-
acetate was added. The final concentration of ethanol (0.18%) 
present in treated and control cells was the same. The amount 
of label incorporated into each glycosphingolipid was determ-
ined by scrapping each individual band after HPTLC chromato-
graphy and quantitating by liquid scintillation. Each band 
was scraped and placed in a 7 ml scintillation vial and 0.5 ml 
water was added. The vial was sonicated and 5.0 ml Aquasol 
was then added and the vial was vortexed. 
The labeling pattern was also observed using a radio-
active thin layer chromatography scanner (RTLC - Radiomatic 
Instruments, Tampa, Fl) which is comprised of a position 
sensitive proportional counter and a multichannel analyzer. 
A TLC plate was placed very close to the analyzer and an inert 
gas (P-10) was injected between the plate and the analyzer. 
The analyzer detected the a-particles along an entire TLC lane 
and bands of greater than 1.0 mm were resolved and the results 
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were automatically analyzed by computer. Scans were usually 
run for 10 mins. 
AUTORADIOGRAPHY 
To detect radioactivity on TLC plates," they were first 
sprayed with ENHANCE (New England Nuclear). The plates were 
then placed on top of X-omat autoradiography film (Kodak 
Company) and exposed for one week at -ao0c.~ 
INHIBITORS OF INTRACELLULAR TRANSPORT 
All inhibitors used in this study were dissolved in 
pure ethanol except for cobalt (CoC1 2-6H20) which was 
dissolved in water. The concentrations of inhibitors used are 
presented in the results section. Whenever a drug was 
dissolved in ethanol an equal amount of ethanol was added to 
the control. The concentrations of inhibitors used was 
determined form dosages recommended in the literature. 
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MICROSCOPY/PHOTOGRAPHY 
Microscopy was done with an inverted 01 ympus microscope 
(phase contrast) hooked up to an Olympus automatic exposure 
adapter. All photographs presented in this djssertation were 
done at a magnification of 100 X with the exposure set at 1 
and reciprocity set at 2. Any glial cells present were 
identified by their characteristic flat poly9onal shape. Most 
observable cells were rounded and extended several neurites 
which is characteristic of neurons. Many of these extended 
neurites had observable growth cones and many were touching 
other cells which is also characteristic of neurons. 
DATA ANALYSIS 
All experiments were performed on at least triplicate 
samples. The standard deviation was determined for all graphs 
and tables. Each experiment was repeated at least three times 
and similar results were obtained for all reported data. The 
monensin and the nigericin data were repeated 5 times. 
Statistical analysis was performed on all data points using 
the Student t test (unpaired, two tailed). The P values were 
calculated for all data points and given in figure legends. 
CHAPTER IV 
RESULTS 
Dissociated neuronal cells prepared from 7 or 8 day 
chick embryonic telencephalon attached to poly-L-lysin,e coated 
dishes within 15 minutes of plating and were well dispersed. 
After 24 hours, most neurons displayed short unipolar, bi-
polar, or multipolar processes and remained dispersed. The 
cells began to form small aggregates after 48 hours and neur-
ites could be observed contacting other cel~s. On the 3rd or 
4th day the media was changed to a defined media without serum 
so that cells were not subjected to the variability of serum 
1 ots or to the presence of proteins and 1 i pi ds which may 
interfere with analysis of the cells. At 6 days, in culture 
cell number was stabilized and there was a fine neuritic 
network with some of the neurites displaying fasciculation. 
A few of the neurites could be found suspended above the 
surface of the dish between two small aggregates. An initial 
cell concentration of sx106 per 100 mm petri dish was found to 
provide the best dispersion of cells on the dish so that large 
aggregates did not form. This allowed easy access for any 
drug treatment and also provided enough cells for lipid 
analysis. The purity of the neuronal cultures was high (>98 
%) since there were very few observable glial cells at 6 days 
in culture. Gl ial cells were flat and polygonal in shape. 
Neurons had long thin neurites extending from the cell body. 
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Many of these neurites exhibited growth cones. Most of the 
neurites were extended and touched other cells. A majority of 
the cells, therefore, exhibited classical neuronal morpho-
metry. Viability of the cultures remained >95 % as determined 
by trypan blue exclusion during all testing procedures. These 
6 day old pure, viable, and cytodifferentia~ed neurons were 
used as standard conditions for all studies (Figure 6). The 
concentrations of all inhibitors used in this study were 
recommended in the literature as being effective. 
Gangliosides, neutral glycolipids, and ceramide were 
extracted from the primary neurons by silicic acid chromato-
graphy as described in Methods. A new solvent system (CHC1 3-
MeOH-0.25 % CaC1 2 54:42:10 (v:v:v)) was developed to provide 
optimal high performance thin layer chromatographic (HPTLC) 
separation of the more complex gangliosides found in neurons. 
The resorcinol staining pattern of primary neuronal ganglio-
sides separated by HPTLC is shown in Figure 7. All ganglio-
sides were well resolved. Ganglioside standards showed linear 
standard curves. The gangliosides GD3 and GM2 were present as 
a doublet which was caused by differences in the long chain 
fatty acids. There is an unidentified resorcinol positive 
band just below GQ1b which may be a higher sialylated ganglio-
side so the band was given the designation GPX (G=ganglioside, 
P=po l ys i a 1 o, X=unknown). The GD2 band might contain sma 11 
amounts of GT1a and GT3 because they comigrate in this region 
and could not be separated. 
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The densitometric scan of Figure 7 is shown in Figure 
a. Integration of the densitometric scan and quantitation of 
the individual ganglioside species is presented in Table 1. 
Peak area was determined by cutting out each peak and weigh-
ing. Every ganglioside was quantitated by comparing each to 
ganglioside standards. The ganglioside standard graphs were 
linear for the concentrations studied. 
TABLE 1 
Quantitation of gangliosides present in primary 
neurons cultured for 6 days in culture. 
GM3 1.6 ± 0.4 
GM2 0.7 :t 0.2 
GM1 0.7 ± 0.2 
GD3 4.5 ± 1. 1 
GD1a 1. 7 ± 0.2 
GD2 1. 9 ± 0.4 
GD1b 0.6 ± 0. 1 
GT1b 12.2 ± 1.1 
GQ1b 9. 1 ± 2.3 
GPX 8.8 ± 1. 9 
Ganglioside µg/mg Cellular Protein (n=3, ± SD) 
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The HPTLC separation of neutral glycolipids is shown 
in Figure 9. Glucosylceramide (Glucer) and lactosylceramide 
(Laccer) the ganglioside precursors were well separated from 
the other neutral glycolipids. Both Glucer and Laccer were 
found in low concentration and several dishes of cells were 
combined to provide enough neutral glyco\ipid for HPTLC 
analysis ( lane 1). Laccer was difficult to see even after 
combining several plates and so could not be accurately 
quantitated. An unidentified band (probably trihexosyl-
ceramide-CTH) was also present in primary neurons. Near the 
solvent front was a band containing various phospholipids. 
Ceramide, the precursor to glucosylceramide, was also 
analyzed by thin layer chromatography (Figure 10). There was 
a nice separation of ceramide from cholesterol, triglycerides 
and fatty acids, cholesterol esters, and the phospholipids. 
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flADIOACTIVE LABELING OF GLYCOSPHINGOLIPIDS. 
Gangliosides were labeled with [3H]-galactose in order 
to analyze new biosynthesis. Incorporation of [3H]-galactose 
into gangliosides was assayed by first separating the ganglio-
sides by HPTLC then directly measuring the radioactivity in 
each band by using a radiochromatographic TLC scanner (Figure 
11) or by autoradiography (Figure 12) or by scraping individ-
ual bands and determining the level of radtoactivity using a 
liquid scintillation counter (Figure 16-see control). RTLC 
scans and autoradiograms were used only for qualitative 
ana 1 ys is but are important in confirming the quantitative 
assessment by scraping. The autoradiogram is also important 
for determining the position of labeled bands. Quantitation 
was established by scraping i ndi vi dual bands separated by 
HPTLC (Figure 16-control). The highest incorporation of label 
was found to be in the ganglioside GD3 (both lower and upper 
bands of GD3 were combined). There was also significant 
uptake of label into GD1 a, GD2, GT1 b, GM3, and GQ1 b. Lower 
amounts of label were found in GM1, GM2, GD1b and GPX. When 
you look at the specific radioactivity of each ganglioside, 
the higher gangliotetraosyl gangliosides (GT1b, GQ1b, and GPX) 
have a much lower specific activity then the other ganglio-
sides (Figure 13-control). The specific activities of GD1b, 
GD2, GD1a, GD3, GM1, and GM3 were similar. 
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Neutral glycolipids were also examined for 
incorporation of [3H]-galactose after incubation for 16 hours 
with the label. The radioactive TLC scan is shown in Figure 
14. There was significant labeling of glucosylceramide, 
lactosylceramide, and trihexosylceramide. Glucosylceramide 
incorporated the most label. Scraping of the jndividual bands 
yielded the following results (Table 2). 
Table 2 
Incorporation of [3H]-galactose into neutral glycolipids 
of primary neurons 16 hours after addition of label. 
GLUCOSYLCERAMIDE 555 ± 80 
LACTOSYLCERAMIDE 80 ± 10 
(cpm/mg protein)(n=4, ± SD) 
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MONENSIN TREATMENT 
Cu 1 tu res of primary neurons were treated with monens in 
and were observed for any morphological changes (Figure 15). 
When compared next to a control culture it becomes evident 
that there was a significant reduction in the neuritic network 
after 18 hour treatment with 100 nM monensin. Neurite retrac-
tion began to occur after about 8 hours. Cells maintained 
greater than 95% viability for up to 25 hou.rs treatment with 
monensin (100 nM). On close examination it could be seen that 
it was the fine neurites and the branching neurites which 
appeared to be most affected and that the 1 arger 1 onger 
neurites remained. Many of these longer neurites appeared to 
end in growth cones or to extend between two sma 11 aggregates. 
The individual gangl ioside concentrations after monen-
sin treatment for 15 hours, compared to control, is shown in 
Table 3. There were no significant changes in the total 
ganglioside concentration after treatment with monensin. The 
loss of neurites does not effect the concentration of ganglio-
sides present. The bulk of the gangliosides may be in the 
large longer neurites which remain after monensin treatment 
and this may support the evidence that gangliosides were found 
in highest concentration in nerve endings. 
Table 3 
Quantitation of ganglios1des in primary neurons which 
have been treated with or without monensin. 
GANGLIOSIDE CONTROL MONENSIN 0.1 
.. 
GM3 1.6 ± 0.4 1.7 ± 
GM2 0.7 ± 0.2 0.7 ± 
GM1 0.7 ± 0.2 0.8 ± 
GD3 4.5 ± 1. 1 4.5 ± 
GD1a 1. 7 ± 0.2 1.9 ± 
GD2 1. 9 ± 0.4 1.4 ± 
GD1b 0.6 ± 0. 1 0.6 ± 
GT1b 12.2 ± 1.1 10.5 ± 
GQ1b 9. 1 ± 2.3 8.7 ± 
GPX 8.8 ± 1.9 8.2 ± 
µg ganglioside/mg total protein (n=3, ± SD) 
No significant difference was found between 
control and monensin treated cultures. 
0. 1 
0. 1 
0. 1 
0. 1 
0.3 
0.2 
o.o 
1.1 
0.8 
0.5 
µM 
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Neuronal cultures were incubated with [3HJ-galactose 
and with or without (control) 100 nM monensin for 15 hours. 
Gangl iosides were then extracted and the amount of label 
incorporated into individual gangliosides was determined 
(Figure 13-CPM/µg ganglioside or Figure 16-CPM/mg protein). 
Incubation of eel ls with monensin resulted. in a selective 
decrease in labeling of individual gangliosides (Figure 16). 
The labeling of GM3 after monensin treatment was unaffected 
while all the other gangliosides had reduc&Et labeling but to 
varying extents. Labeling of GT1b was reduced almost 80 % and 
GPX about 74% after monensin treatment. Monensin also signif-
icantly reduced the labeling for G01a (69%), GD1b (66%), GM1 
( 52%), and GQ1 b ( 52%) . Labe 1 i ng was reduced to a 1 esser 
extent in GD3 (40%) and GM2 (39%). 
The rate of incorporation was examined by labeling 
([ 3H-galactose) of the gangliosides over an 18 hour time span 
(Figures 17 to 26). The uptake of label into individual 
gangl iosides was found to exhibit a slow initial phase of 
label incorporation for about 4 to 6 hours. This slower phase 
was followed by a faster incorporation of label which leveled 
off after about 12-15 hours. Label was incorporated most 
rapidly into GD3 (Figure 23) but there was also significant 
labeling of GD1a (Figure 22); GD2 (Figure 21); GT1b (Figure 
19); GQ1b (Figure 18); and GM3 (Figure 26). Lower levels of 
labeling were found for GD1b (Figure 20); GPX (Figure 17); GM1 
(Figure 24); and GM2 (Figure 25). GM3 was the only ganglio-
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side which showed no difference in the rat~ of incorporation 
of label in monensin treated cultures as compared to controls 
from 9 up to 18 hours treatment (Figure 26). There was a 
small decrease in labeling of GM3 after 3 and 6 hours treat-
ment with monensin. In contrast the labeling of GT1b (Figure 
19) was the ganglioside most significantJy inhibited by 
monensin over time. Next to GM3, the ganglioside GD3 (Figure 
23) had the least inhibition of the incorporation of label 
over all time points. The time courses for·~the incorporation 
of label into GD1a (Figure 22); GD2 (Figure 21); GQ1b (Figure 
18); GD1b (Figure 20); and GPX (Figure 17) also showed signif-
icant reduction in labeling after treatment with monensin. 
Gangliosides GM1 (Figure 24) and GM2 (Figure 25) had inter-
mediate inhibition of labeling when monensin was added. 
Primary neurons were also treated with nigericin which 
has a close structural relationship to monensin. Neurons were 
labeled with [3H]-galactose and treated with or without 0.1 µM 
nigericin (Figure 51). The inhibition of the incorporation of 
label by nigericin was similar to that of monensin. Label 
incorporation into GM3 was unchanged after treatment with 
nigericin. Incorporation of label into GD3 was reduced about 
40 % by nigericin. The gangliosides (GPX, GQ1b, GT1b, GD2, 
GD1b, GD1a, and GM1,) all had decreased labeling when niger-
icin was added. 
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Neutral glycolipids were also examined for incorpor-
ation of [3H]-galactose with and without 0.1 µM monensin or 
nigericin added for 16 hours (Table 4). 
TABLE 4 
Effect of monensin and nigericin on the incorporation of 
[ 3H]-galactose into neutral glycolipids of primary neurons 
after treatment for 16 hours. 
LACTOSYLCERAMIDE GLUCOSYLCERAMIDE 
CONTROL 80 ± 10 . 555 ± 80 
MONENSIN O .1 µM 157 ± 138 545 ± 65b 
NIGERICIN 0. 1 µM 127 :t 18 520 ± 54b 
CPM/mg Protein (n=3, ± SD)( 8p<.01, bnot significant) 
Both monensin and nigericin caused almost a doubling 
in labeling of lactosylceramide. Glucosylceramide labeling in 
the presence of monensin or n1gericin was not significantly 
affected. 
Incorporation of [ 3H ]-gal actose into neutral 
glycolipids was examined over a 24 hour period (Figure 27 and 
28). Labeling of glucosylceramide (Figure 28) was very fast 
and no initial lag phase was observed but the labeling slowed 
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after 8 hours. Initial labeling of lactosylceramide (Figure 
27) was slower for up to 4 hours and then increased. Monensin 
(0.1 µM) treatment resulted in a significant increase of 
lactosylceramide labeling over time. There was no inhibition 
of labeling of lactosylceramide up to 4 hours but after 8 
hours treatment with monensin there was an increase in the 
incorporation of label. At longer time points (20 and 24 
hours) there was a significant increase in labeling of 
lactosylceramide caused by monensin ( Figure--27). There was no 
significant change in labeling of glucosylceramide caused by 
monensin treatment (Figure 28). 
The precursor ceramide was analyzed by labeling 
primary neurons with c14c]-acetate and incubating the cells in 
the pres.ence or absence of o. 1 µM monens in (Figure 29). 
Monensin had no effect on the incorporation of label into 
ceramide when compared to control. When the ceramide band was 
scraped, and the amount of label incorporated was analyzed, 
the results confirmed the RTLC scan (Table 5). 
TABLE 5 
Effect of monensin on the incorporation of 
c14cJ-acetate into ceramide of primary neurons 
after the addition of label for 16 hours. 
-CONTROL 1943 ± 318 
MONENSIN (0.1 µM) 1~5 ± 259 
(cpm/mg protein)(n=4, ±SD)~ 
No significant difference was found between 
control and monensin treated cultures. 
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To further observe the effect that monensin has on 
ganglioside metabolism and to specifically label on,y 
gangliosides, the label D-[1- 14c]-N-acetyl-mannosamine was 
utilized. N-acetyl-mannosamine is the precursor to sialic 
acid and so will only label sialic acid groups in the 
gangliosides. Neutral glycolipids will not become labeled. 
This label was added with or without monensin (0.1 µM) and the 
incorporation was examined at 5, 10, and 15 hours (Figures 30 
to 39). Label incorporation into most of these gangliosides 
is represented by a sigmoidal curve. Gangliosides with low 
label incorporation had an initial lag phase of incorporation 
and then a faster phase before leveling off ( GM1, GM2, and 
GM3). When there was a high level of incorporation there was 
an initial fast incorporation of label followed by a leveling 
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off before increasing again (GPX, GQ1b, GT1~, GD1a). GT1b had 
the largest incorporation of label (Figure 32). GD3 (Figure 
36); GQ1b (Figure 31); and GPX (Figure 30) were also highly 
labeled. Lower levels of label were seen in GD2 (Figure 34); 
GD1a (Figure 35); GM3 (Figure 39); and GD1b (Figure 33). The 
lowest labeling was found in GM2 (Figure 38):and GM1 (Figure 
37). The labeling of GM3 by N-[ 14c]-acetyl-mannosamine was 
unaffected by monensin treatment except at 5 hours where there 
was a small increase in labeling. The inhib~tion of labeling 
of GD3 by monensin (Figure 36) resembled the inhibition of 
labeling seen for [3H]-galactose (Figure 23). The ganglioside 
GPX seems to be the most affected by monens in treatment 
(Figure 30). GD1b (Figure 33); GD1a (Figure 35); GT1b (Figure 
32); GQ1b (Figure 31); GD2 (Figure ~4); and GM1 (Figure 37) 
all exhibit similar inhibition of labeling profi las when 
treated with monens in. GM2 was the on 1 y gang 1 i os i de whose 
monensin inhibition differed greatly between c14c]-N-acetyl-
mannosamine and [ 3H]-galactose labeling. There was a signif-
icant inhibition of [3H]- galactose labeling of GM2 caused by 
monensin (Figure 25) but there was no change in labeling when 
[ 14c]- N-acetyl-mannosamine was used to label cells (Figure 
38). 
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Other pharmacological agents which are known to 
interfere with intracellular transport were examined for their 
effect on radiolabel ing of glycosphingol ipids. Colchicine, 
which causes a depolymerization of microtubules and thus 
interferes with transport processes, was added ( 1 µM) to 
primary neurons. Morphology of the neurons was altered by 
col chic i ne and the change was similar to that seen for 
monensin treatment {Figure 40). There was a decrease in size, 
number, and complexity of neurites when colchicine was added 
to primary neurons, but the long axonal like processes 
remained. Vinblastine, another agent which disrupts 
microtubules, also caused a reduction in the neuritic network 
(Figure 41). Vinblastine has been reported to cause 
crystallization of free tubulin which may result in the grainy 
appearance of the remaining neurites. Cytochalasin D is a 
cytoskeletal antagonist which blocks polymerization of actin 
molecules and thus inhibits microfilament contraction but is 
not thought to interfere with intraneurite transport. When 
cytochalasin D was added to primary neurons there seemed to be 
no reduction in the neuritic network as seen with the other 
cytoskeletal inhibitors but there actually appeared to be a 
slight increase in the neurite complexity when compared to 
control (Figure 42). 
The effect of these three inhibitors (colchicine, 
vinblastine, and cytochalasin D) on the incorporation of [3HJ-
galactose into gangliosides and neutral glycolipids was 
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examined. Primary neurons treated with or without colchicine 
(1.0 µM) are shown in Figure 43 and 44. The labeling of most 
of the gangliosides was inhibited by colchicine including GPX, 
GQ1b, GT1b, GD1b, GD2, and GD1a. GT1b and GD1a labeling was 
inhibited to the greatest extent by colchicine. Interest-
ingly, labeling of GD3 and GM3 was unaffected by colchicine 
treatment. 
The inhibitor cytochalasin D ( 1.0 µM) had little 
effect on the labeling of gangliosides by [3HJ-galactose 
(Figure 45). There was some decrease in labeling of GT1b when 
cytochalasin D was added and a smal 1 increase in GM1. This 
data agrees with the report that cytocha las in D does not 
interfere with intraneurite transport. 
When vinblastine ( 1.0 µM) was added to primary 
neurons, the effect seen on labeling was similar to that of 
colchicine but with some distinct differences (Figure 46). 
GT1b was decreased in radioactive labeling the most followed 
by GD1a and then GQ1b. GD3 had a small increase in labeling 
and GM3 was unaffected by vinblastine treatment. Labeling of 
GM2 was slightly enhanced by vinblastine which was different 
from treatment with colchicine. Over a 11, the cytoske l eta 1 
inhibitors (colchicine, vinblastine, and cytochalasin D) 
caused less inhibition of labeling than did monensin. This 
may be due to the fact that monensin has a direct effect on 
Golgi transport whereas the cytoskeletal inhibitors only have 
an indirect effect on Golgi transport. 
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The effect of colchicine and cytochalasin Don neutral 
glycolipids is presented in Table 6. 
TABLE 6 
Effect of cytochalasin D and colchicine on the 
incorporation of [ 3H]-galactose into ne~tral glycolipids 
of primary neurons when treated for 15 hours. 
LACTOSYLCERAMIDE Gl:,_UCOSYLCERAMIDE 
CONTROL 15 ± 1.5 106 ± 13 
CYTOCHALASIN D 13 ± 2. 3b 95 ± 15b 
COLCHICINE 11 ± 0. 78 122 ± gb 
(cpm/mg protein) (n=3, ± SD)( 8p<.05, bnot significant) 
Drugs were added at a concentration of 1.0 µM. 
Treatment of primary neurons with cytochalasin Dor 
colchicine had no effect on the labeling of glucosylceramide 
has shown in Table 6. Cytochalasin D also had no effect on 
the labeling of lactosylceramide but colchicine caused a small 
decrease in its labeling. 
Cobalt is thought to specifically inhibit transport 
between the endoplasmic reticulum and the Golgi apparatus and 
so was used to examine g l ycosph i ngo l i pi d tr ans po rt. The 
higher gangl iosides GPX, GQ1b, and GT1b, had a significant 
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reduction in the incorporation of [3H]-galactose when cobalt 
(0.5 mM CoC1 2-eH20) was added to the media which was similar 
to that of monensin (Figure 47a and 47b). Cobalt was also 
s i mi 1 ar to monens in because GM3 had no reduction in 1 abe 1 
incorporation. GD3 incorporation of label was also unchanged 
after treatment with cobalt. There was a slight reduction in 
label incorporation of GD1a and no significant change in GD2 
after treatment with cobalt. The most significant difference 
between cobalt and monensin treatment was the incorporation of 
label into GM2. Cobalt caused a large increase in the incor-
poration of label into GM2 but monensin did not. This is 
significant because GM2 is the first step of the "a" series 
after branching from GM3. Another significant difference 
between cob a 1 t and monens in was that coba 1 t significant 1 y 
enhanced the incorporation of label into glucosylceramide but 
reduced the label incorporation into lactosylceramide (Figure 
48 and Tab 1 e 7). This suggested that coba 1 t interfered at 
another earlier step in the biosynthesis of gangliosides than 
did monensin. 
TABLE 7 
Effect of cobalt on the incorporation of 
[ 3H]-galactose into neutral glycolipids of 
primary neurons after treatment for 18 hours. 
LACTOSYLCERAMIDE GLUCOSYLCERAMIDE 
CONTROL 22 ± 1.0 
-
66 ± 1.5 
COBALT 0.5 mM 13 ± 1 • 28 141 ± 8. 74 
(cpm/mg protein) (n=3, ± SD) (8p(0.001) 
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To discover if calcium has a role in glycosphingolipid 
biosynthetic pathways the calcium ionophore A23187 was used to 
increase the intracellular concentration of this ion. When 
A23187 (1.0 µM) was added along with [3HJ-galactose to primary 
neurons there was almost a complete abolition of the incorpor-
ation of label into GPX, GQ1b, GT1b and GD1a suggesting an 
important role of calcium in ganglioside transport (Figure 49a 
and 49b). Incorporation of label into GM3 remained unchanged. 
A23187 caused a significant enhancement of label incorporation 
into both GD3 and GM2. Both GD3 and GM2 are the first step in 
the "b" series and the "a" series respectively, therefore, 
calcium may play an important role in regulation of ganglio-
side biosynthesis. Interestingly, A23187 had no effect on the 
incorporation of label into both lactosylceramide and 
glucosylceramide (Figure 50 and Table 8). 
TABLE 8 
Effect of A23187 on the incorporation of 
[ 3H]-galactose into neutral glyco1ipids of 
primary neurons after treatment for 15 hours. 
LACTOSYLCERAMIDE GLUCOSYLCERAMIDE 
CONTROL 36 ± 1. 2 162 ± 4.5 
A23187 1.0 µM 27 ± 2. 58 147 ± 14. ob 
(cpm/mg protein)(n=3, ± SD)( 8p<O.01, bnot significant) 
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Figure 1 
Biosynthesis of ceramide 
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Figure 2 
Ganglioside biosynthesis 
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Figure 3 
Structure of GM3 
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1. RECEPTORS 
A. HORMONES (TSH,HCG,etc.) . 
B. CELL GROWTH FACTORS (NGF) 
C. DIFFERENTIATION FACTORS. 
D. INTERFERON 
E. LECTINS 
F. NEUROTRANSMITTERS 
G. ETC. 
2. NEURITOGENIC AND NEUROTROPHIC EFFECTS 
3. CELL RECOGNITION 
4. CELL ADHESION AND MIGRATION 
5. DIFFERENTIATION 
6. ELECTRICAL EXCITABILITY 
7. CONTROL OF MEMBRANE IONIC ENVIROMENT 
8. MANY OTHER MEMBRANE RELATED PHENOMENA 
Figure 4 
Functions attributed to gangliosides 
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Figure 5 
Structure of Monensin 
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Figure 6 
Chick primary neurons prepared from 7 day old embryo 
telencephalon and grown for six days in culture. 
(Magnification 100 X) 
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GD1a • 
GD2 • ( 
GD1b • 
GT1b • 
GQ1b • GPX • 
A B 
Figure 7 
Gangliosides were isolated from 7 day primary neurons. 
Individual gangliosides were separated by HPTLC. 
The HPTLC plate was then sprayed with resorcinol. 
A. Ganglioside pattern of chick primary neurons. 
B. Ganglioside standards 
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Figure 8 
Densitometric scan of Figure 7. Peak area was quantitated 
by cutting out individual peaks and weighing each one. 
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Neutral glycolipids were isolated from 7 day primary 
neurons. Individual neutral glycolipids were separated 
by HPTLC. The HPTLC plate was sprayed with anthrone 
reagent. 
Lane 1 Neutral glycolipids of chick primary neurons 
Lane 2 Galactosylceramide standard 
Lane 3 Glucosylceramide standard 
Lane 4 Lactosylceramide standard 
Lane 5 Sulfatide standard 
Lane 6 Mixture of neutral glycolipid standards 
(CTH = Trihexosyl ceramide) 
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Figure 10 
CERAMIDE ANALYSIS 
Lipids were isolated from 7 day primary neurons. 
These lipids were separated by HPTLC. The HPTLC plate 
was charred with phosphoric acid/cupric acetate reagent. 
Band 1 Phospholipids 
Band 2 Cholesterol 
Band 3 Triglycerides and fatty acids 
Band 4 Cholesterol esters 
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5 
Primary neurons were labeled with [3HJ-galactose for 18 hours. 
Gangliosides were isolated and individual gangliosides were 
separated by HPTLC. The HPTLC p 1 ate was p 1 aced under the 
radioactive TLC scanner for 10 mins. The RTLC scan is 
presented. 
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GANGLIOSIIE 
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Figure 12 
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Primary neurons were labeled with [3HJ-galactose for 18 hours. 
Gangliosides were isolated and individual gangliosides were 
separated by HPTLC. The HPTLC plate was sprayed with 
scintillant and exposed to autoradiographic film for 5 days at 
-80 °c. The autoradiogram of the TLC plate is presented. 
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Figure 13 Primary neurons were labeled for 15 hours with 
[ 3H]-galactose. The gangliosides were isolated then separated 
by HPTLC. The specific activity of labeled gangliosides both 
before and after monensin (0.1 µM) treatment for 15 hours was 
determined. Gangl iosides were quantitated by densitometric 
scanning. Specific activity was calculated from the amount of 
radioactivity in each band (CPM) as comP.ared to t,re amount of 
ganglioside (µg) present. (n=3, ±SD, *p<.05, * p<.01). GM3 
was not significantly different from control. 
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Figure 14 
The ne~tral glycolipids of chick primary neurons were labeled 
with [ H]-galactose for 18 hours. Neutral glycol ipids were 
isolated and then separated by HPTLC. The HPTLC plate was 
placed under the radioactive scanner for 10 mins. The RTLC 
scan is presented~ 
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Figure 15 
6 day primary neurons were exposed to 0.1 µM monensin 
for 18 hours. The photograph after monensin treatment 
is presented. (Magnification 100 X) 
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Figure 16 
Primary neurons were labeled with [3HJ-galactose and 
treated with or without 0.1 µM monensin for 18 hours. The 
gangliosides were isolated and then separated by HPTLC. 
Individual gangliosides were scraped and the amount of 
rJdioactivity in each band was determined. (n=3, ± SD, 
* p<.01). GM3 was not significantly different from control. 
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Figure 17 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GPX band was scraped and the radioactivity was determined. 
Open squares represent control and filled squares represent 
monensin treated neurons. (n=3, ± SD, *p<.05). All other 
time points p<.01. 
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Figure 18 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. Ganglio-
sides were isolated and then separated by HPTLC. The GQ1b 
band was scraped and the radioactivity was determined. Open 
squares represent control and fillfd squares represent 
monensin treated neurons. (n;3, ± SD, p<.05, **p<.01). The 
3 hour time point was not significantly different from 
control. 
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Figure 19 
Primary neurons were labeled with [ 3H]-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GT1b band was scraped and the radioactivity was determined. 
Open squares represent control and filled s8.cuares represent 
monensin treated neurons. (n=3, ± SD, * p<.01 for all 
timepoints when compared to control). 
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Figure 20 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GD1b band was scraped and the radioactivity was determined. 
Open squares represent control and filled squares represent 
monensin treated neurons. {n=3, ± SD, **p<.01 for all time 
points when compared to control). 
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Figure 21 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GD2 band was scraped and the radioactivity was determined. 
Open squares represent control and fillf2 squares represent 
monensin treated neurons. (n=3, ± so, p<.01 for all time 
points when compared to control). 
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Figure 22 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GD1a band was scraped and the radioactivity was determined. 
Open squares represent control and fillli squares represent 
monensin treated neurons. (n=3, ± SD, p<.01 for all time 
points when compared to control). 
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Figure 23 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GD3 band was scraped and the radioactivity was determined. 
Open squares represent control and fille1 squares represent 
monensin treated neurons. (n=3, ± SD, * p<.01 for all time 
points except 9 hour (*p<.05) when compared to control). 
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Figure 24 
Primary ne• '-Jrons were labeled with [3HJ-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosid •es were isolated and then separated by HPTLC. The 
GM1 band wa---as scraped and the radioactivity was determined. 
Open squar• Es represent contro 1 and f i 11 I~ squares represent 
monensin tt reated neuro~s. (n=3, ± SD, p<.01 for all time 
points exc•=ept 9 hour ( p<.05) when compared to control). 
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Figure 25 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GM2 band was scraped and the radioactivity was determined. 
Open squares represent control and fille1squares represent 
monensin treated neurons. (n=3, ±SD, * p<.01 for all time 
points except 9 hour (not significant) when compared to 
control). 
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Figure 26 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. 
Gangliosides were isolated and then separated by HPTLC. The 
GM3 band was scraped and the radioactivity was determined. 
Open squares represent control and filled squares represent 
monensin treated neurons. (n;J, ± SD, *p<.05, other time 
points were not significant when compared to control. 
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Figure 27 
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20 24 
Primary neurons were labeled with [3H]-galactose and treated 
with or without 0.1 µM monensin for various times. Neutral 
glycolipids were isolated and then separated by HPTLC. The 
lactosylceramide band was scraped and the radioactivity was 
determined. Open squares represent control and filled 
iiuares represent monens_i n treated ce 11 s. ( n=3, ± so, 
p<.01, other time po1nts were not significant when 
compared to control. 
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Figure 28 
16 20 24 
82 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 0.1 µM monensin for various times. Neutral 
glycolipids were isolated and then separated by HPTLC. The 
glucosylceramide band was scraped and the radioactivity was 
determined. Open squares represent contro 1 and f i 11 ed 
squares represent monensin treated cells. (n;3, ± SD) All 
time points were determined to be not significant when 
compared to control. 
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Figure 29 
Primary neurons were labeled with [ 14 CJ-ac~tate and treated 
with or without 0.1 µM monensin for 15 hours. Lipids were 
isolated and then separated by HPTLC. The HPTLC plate was 
placed under the radioactive TLC scanner for 10 mins. 
Peak 1 phospho lipids, Peak 2 cho l estero 1 , Peak 3 trig l y-
ceri des and fatty acids, Peak 4 cholesterol esters 
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Figure 30 
Primary neurons were labeled with c14cJ-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GPX band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squar1s - mon1gsin (0.1 µM) treated cells. 
(n=3, ± SD, p<.05, p<.01) 
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Figure 31 
Primary neurons were labeled with c14 c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GQ1 b band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squaris - moninsin (0.1 µM) treated cells. 
(n=3, ± SD, p<.05, *p<.01) 
C 
.i> 
..... 
0 
L 
0. 
0\ 
E 
'---~ 
n. 
0 
120 r------.------------~---
GTlb 
100 
80 
60 
40 
20 
o _______ ...._ _____ L_ ____ __JL__ _ _J 
0 5 10 
HOURS 
Figure 32 
15 
86 
Primary neurons were labeled with c1•c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GT 1 b band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squares - monensin (0.1 µM) treated cells. 
(n=3, ± SD, **p<.01 for all time points when compared to 
control. 
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Figure 33 
Primary neurons were labeled with [ 14CJ-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GD1b band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squares - monensin (0.1 µM) treated cells. 
(n=3, ± SD, **p<.01 for all time points when compared to 
control. 
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Figure 34 
Primary neurons were labeled with [ 14c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GD2 band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squarit - monensin (0.1 µM) treated cells. 
(n=3, ± SD, p<.01 for all time points except 5 hour (not 
significant) when compared to control. 
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Figure 35 
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89 
Primary neuror-.s were labeled with c14cJ-N-acetylmannosamine 
and treated W"ith or without 0.1 µM monensin for the times 
indicated. Gangl iosides were isolated and then separated by 
HPTLC. The GD1 a band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled square~ - monensin (0.1 µM) treated cells. 
(n=3, ± so, p< .05, **p< .01, 5 hour time point was not 
significant when compared to control. 
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Figure 36 
15 
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Primary neurons were labeled with [ 14cJ-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GD3 band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squaris - moniQsin (0.1 µM} treated cells. 
(n=3, ± SD, p<.05, p<.01) 
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Figure 37 
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Primary neurons were labeled with c14c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GM1 band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squarei - monensin (0.1 µM) treated cells. 
(n=3, ± SD, p<.05, **p<.01, 5 hour time point was not 
significant when compared to control. 
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Figure 38 
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Primary neurons were labeled with r14c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GM2 band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squares - monensin (0.1 µM) treated cells. 
(n=3, ± SD, All time points were not significant when 
compared to control). 
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Figure 39 
15 
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Primary neurons were labeled with [ 14c]-N-acetylmannosamine 
and treated with or without 0.1 µM monensin for the times 
indicated. Gangliosides were isolated and then separated by 
HPTLC. The GM3 band was scraped and the amount of 
radioactivity was determined. Open squares - control 
Filled squares - monensin (0.1 µM) treated cells. 
(n=3, ± SO, All time points were not significant except for 
the 5 hour time point <*p<.05) when compared to control. 
Figure 40 
6 day primary neurons were exposed to 1.0 µM 
colchicine for 16 hours. The photograph of 
colchicine treated neurons is presented. 
(Magnification 100 X) 
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Figure 41 
6 day primary neurons were exposed to 1.0 µM 
vinblastine for 16 hours. The photograph of 
vinblastine treated neurons is presented. 
(Magnification 100 X) 
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Figure 42 
6 day primary neurons were exposed to 1.0 µM 
cytochalasin D for 16 hours. The photograph of 
cytochalasin D treated neurons is presented. 
(Magnification 100 X) 
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Figure 43 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 1.0 µM colchicine for 15 hours. Gangliosides 
were isolated and then separated by HPTLC. Individual 
gang 1 i os i de bands were scraped and the amount of 
radioactivity in each band was determined. (n=3, ± SD, 
*p<.05, **p<.01, remaining time points were not significant 
when compared to control. 
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Figure 44 
Primary neurons were labeled with [3HJ-galactose and treated 
with or without 1.0 µM colchicine for 15 hours. 
Gangliosides were isolated and then separated by HPTLC. The 
HPTLC plate was placed under a radioactive TLC scanner for 
10 mins. The RTLC scan comparing control (dotted line) to 
colchicine treated (solid line) is presented. 
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Primary neurons were labeled with [3HJ- galactose and 
treated with or without 1.0 µM cytochalasin D for 15 hours. 
Gangliosides were isolated and then were separated by HPTLC. 
Individual ganglioside bands were scraped and the amount of 
radioactivity in each band was determined. (n=3, ± so, 
*p< .05, remaining time points were not significant when 
compared to control. 
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Figure 46 
Primary neurons were labeled with [ 3HJ-galactose and treated 
with or without 1.0 µM vinblastine for 15 hours. 
Gangliosides were isolated and then were separated by HPTLC. 
Individual bands were scraped and the amount of 
radioactivity in each band was determined. (n=3, ± SD, 
*p<.05, **p<.01, remaining time points were not significant 
when compared to control. 
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Figure 47a 
Primary neurons were labeled with [3HJ- galactose and 
treated with or without cobalt (0.5 mM cocl 2-aH2o) for 18 hours. Gangl iosides were isolated and then separated by 
HPTLC. The HPTLC plate was placed under a radioactive TLC 
scanner for 10 mins. The RTLC scan of control (dotted line) 
was compared to cobalt treated (solid line) neurons. 
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Figure 47b Primary neurons were labeled with [3HJ- galactose and 
treated with or without cobalt (0.5 mM Cocl 2-6H20) for 18 hours. Gangliosides were isolated and then separated by HPTLC. Individual 
ganglioside bands were scraped and the amount of radioactivity in 
each band was determined. (control-open bars, cobalt-hatched 
bars)(n=3, ± SO, *p<.05, **p<.01, remaining time points were not 
significant when compared to control). 
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Figure 48 
The neutral glycolipids of chick primary neurons were 
labeled with [3H]-galactose and treated with or without 
cobalt (0.5 mM CoCl 2-aH2o) for 18 hours. Neutral glycolipids 
were isolated and then separated by HPTLC. The HPTLC plate 
was placed under the radioactive TLC scanner for 10 mins. 
The RTLC scan of contro 1 ( dotted 1 i ne) was compared to 
cobalt treated (solid line) neurons. 
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Figure 49a 
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Primary neurons were labeled with [3HJ-galactose and treated 
with or without 1.0 µM A23187 for 15 hours. Gangliosides 
were isolated and then separated by HPTLC. The HPTLC plate 
was placed under a radioactive TLC scanner for 10 mins. The 
RTLC scan of control (dotted line) was compared to A23187 
treated (solid--line) neurons. 
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Figure 49b Primary neurons were labeled with [3HJ-galactose and treated with 
or without 1.0 µM A23187 for 15 hours. Gangliosides were isolated and then 
separated by HPTLC. Individual gangliosides were separated by scraping and 
the amount of radioactivity in each band was determined. (control-open bars, 
A23187-hatched bars)(n=3, t SD, *p<.05, **p<.01, remaining time points .were 
not significant when compared to control). 
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Figure 50 
Primary neurons were labeled with L3H]-galactose and treated 
with or without 1.0 µM A23187 for 15 hours. Neutral 
glycolipids were isolated and then separated by HPTLC. The 
HPTLC plate was placed under a radioactive TLC scanner for 
10 mins. The RTLC scan of control (dotted line) was 
compared to A23187 treated (solid line) neurons. 
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Figure 51 Primary neurons were labeled with [JHJ-galactose and treated with 
or without 0.1 µM nigericin for 18 hours. The gangliosides were isolated and 
then separated by HPTLC. Individual gangliosides were scraped and the amount 
of radioactivity in each band was determined. (Control - open bars, 
nigericin - hatched bars)(n=3, ± SD, **p<.01, remaining time points were not 
significant when compared to control). 
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CHAPTER V 
DISCUSSION 
Gangliosides are major constituents of the nervous 
system and are purported to play a wide variety of roles in 
. 
neuronal functioning (Wiegandt, H. 1982). The biochemical 
metabolism and chemical characterization of gangliosides has 
-been worked out in detail from in vitro studies. Addition of 
activated sugar substrates to ceramide is catalyzed by highly 
.. 
specific glycosyltransferases which add the substrates sequen-
tially (Figure 2). Most of these gly6osyltransferases are 
thought to be located at the luminal surface of the Golgi 
complex (see review). Studies have revealed that the Golgi 
complex is organized and compartmentalized. Some proteins 
which exit the endoplasmic reticulum, via vesicles, enter the 
cis face of the Golgi complex where they pass through the 
medial cisternae and then finally the trans cisternae in a 
sequential manner. Proteins exiting the Golgi complex are 
sorted and transported to there ultimate destination. As 
proteins pass through the Golgi complex they are acted upon by 
various enzyme activities which modify the protein structure. 
Evidence indicates that some of these enzyme activities are 
associated only with the cis, medial, or trans compartments of 
the Go 1 g i complex which a 11 ows for an ordered processing. 
This same ordered processing may be important for metabolism 
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of gangliosides which are thought to pass through the Golgi 
complex. Specific glycosyltransferases may reside in a 
distinct compartment of the Golgi complex. Certain cisternae 
may also contain the postulated multiglycosyltransfera$e 
complexes which are thought to be comprised of two or more 
transferases. The transport of several cla~ses of proteins 
through the Golgi complex can be inhibited by monensin, a 
monovalent cationophore. Monensin specifically disrupts Golgi 
processing events somewhere between th&- cis and trans 
cisternae. This disruption of processing may be a direct 
result of transport inhibition caused by the dilation of the 
cisternae or, as some speculate, may involve a decrease in 
transport of activated sugar substrates from the cytoplasm to 
the 1 umen of the Go 1 g i . Recent evidence indicates that 
monensin does not inhibit activated sugar transport (Capasso, 
1984). In one study there was an accumulation of activated 
sugars in the Golgi lumen of thymocyte cells that are treated 
with monensin (Verbert, §.t . .Al 1987). 
Monensin has been used in C6 and N18 cells (Miller-
Prodraza and Fishman, 1984), fibroblasts (Saito, §.t. u.. 1985) 
and, in this study, on primary neurons to perturb 
glycosphingolipid processing. There are several similarities 
and several distinct differences between primary neurons and 
cell 1 ines when monensin is used to disrupt labeling of 
gangliosides. Primary neurons contain several higher 
gangliosides (GPX, GQ1b, GT1b, G01b, and GD2) which are not 
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found in the other ce 11 1 i nes studied and so can not be 
directly compared. The labeling of GPX, GQ1b, GTlb, GDlb, and 
GD2 is inhibited significantly when primary neurons are 
treated with monensin (Figure 16). Labeling of GD3 is only 
moderately inhibited by monensin in primary neurons (Figure 
23) but is significantly inhibited in fibroblasts. GD1a 
labeling was significantly inhibited by monensin in C6 cells, 
N18 cells, fibroblasts, and in primary neurons (Figure 22) . 
.. 
Labeling of the monosialogangliosides GM1 and GM2, was 
inhibited by monensin in N18 cells, fib~oblasts, and primary 
neurons (Figures 24 and 26). Labeling of GM3 was reduced in 
C6 cells, N18 cells, and fibroblasts after monensin treatment 
but was unchanged in primary neurons (Figure 16) indicating a 
distinct difference between transformed cell lines and primary 
cells. There were also distinct differences in the labeling 
changes induced by monensin between neutral glycolipids in 
cell lines and primary neurons. Glucosylceramide labeling was 
greatly increased in C6 eel ls, N18 eel ls, and fibroblasts 
after treatment with monensin but the labeling of primary 
neurons was not significantly changed (Figure 28). The 
labeling of lactosylceramide was greatly increased in both 
primary neurons (Figure 27) and fibroblasts after monensin 
treatment but was actually reduced in both C6 cells and N18 
cells. These striking differences seen between cell lines and 
primary neurons may suggest altered ganglioside metabolism in 
transformed ce 11 s. The inability of monensin to have any 
1 1 1 
inhibitory effect on the rate (Figure 26) or the specific 
activity of labeling in GM3, suggests that GM3 is synthesized 
in an extra-Golgi compartment. Since there is little change 
in GM3 labeling after monensin treatment this suggests a high 
turnover rate. The location of GM3 in an extra-Golgi 
compartment may be an important control point because 
ganglioside biosynthesis bifurcates at GM3 to form the "a" 
series gangliosides and the "b" series gangliosides. 
Nigericin was also examined for its effect on 
ganglioside anabolism in primary neurons. The results with 
nigericin confirm the results seen with monensin (Figure 51). 
Labeling of GM3 was unaffected by nigericin after 18 hours 
treatment. GD3 was inhibited to a lesser degree by nigericin 
then the other gangl iosides. Nigericin also increased the 
label incorporation into lactosylceramide but had no effect on 
incorporation into glucosylceramide (Table 4). 
These studies on primary neurons were also carried 
out using c14c]- N-acetyl-mannosamine in order to specifically 
label the gangliosides and to determine if there were any 
significant differences when compared to [3HJ-galactose 
1 abe 1 i ng. The i nhi bit ion of gangl ioside 1 abe 1 i ng ( [ 14cJ-N-
acetyl-mannosami ne) caused by monensin was qualitatively 
similar to the inhibition of labeling seen with [3H]-galactose 
except for GM2 (Figures 30 to 39). The labeling of 
gangl ioside GM2 by c14c]-N-acetyl-mannosamine was unaffected 
by monensin treatment (Figure 38) but was inhibited when [3H]-
112 
galactose was used aa a label (Figure 26). 
Cytoskeletal inhibitors provided further evidence for 
the compartmentalization of gangl ioside anabolism. The higher 
gangliosides GPX, GQ1b, GT1b, G01b, G01a, and GD2 had decreas-
ed incorporation of label when treated with colchicine (Figure 
43). There was no change in the labeling of GM3 and GD3 after 
colchicine treatment. Colchicine also had no effect on the 
label incorporation into glucosylceramide but had a small 
inhibitory effect on labeling of lactosylcQramide (Table 6). 
Cytochalasin D (1.0 µM) which inhibits polymerization 
of actin had little effect on the labeling of gangliosides 
(Figure 45) or on neutral glycolipids (Table 6). Although 
cytochalasin D can interfere with microtubule contraction this 
data would suggest that it has little effect on the processing 
events in the Golgi. 
Vinblastine which crystallizes free tubulin caused a 
small increase in labeling of GD3 (Figure 46) and had no 
effect on the labeling of GM3 in primary neurons. The 
labeling of GT1b, GQ1b, and GD1a was inhibited by vinblastine. 
This data with cytoskeletal inhibitors supports the idea out-
lined above that GM3 is regulated differently intracellularly 
than the other gangliosides. That GM3 is unique among gang-
liosides is supported by several other studies. Hela cells 
contain mostly GM3 and G03 and changes in the morphology of 
these cells is closely associated with GM3 synthesis (Fishman 
and Brady, 1976). Rapid differentiation of epithelial cells 
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is also closely associated with GM3 synthesis (Hakomori, 
1981). Epidermal growth factor dependent phosphoryla~ion of 
the EGF receptor appears to be regulated by GM3 (Hanai, 1988) 
and may regulate eel l growth. The growth of 3T3 eel ls, KB 
cells, and A431 cells was inhibited by GM3 (for review see 
Usuk i , 1988) • Usuk i ( 1988) speculates that the removal of 
sialic acid from GM3 at the membrane surface may regulate cell 
growth. The only anabolic defect in ganglioside biosynthesis 
discovered to date was in a patient who possessed only GM3 and 
GD3 in the brain (Kanfer, 1983). GM3 is the major ganglioside 
found in many mammalian tissues. Changes in GM3 levels and in 
GM3 synthetase are associated directly with oncogenic trans-
formation (Hakamori, 1981). The data in this paper supports 
the hypothesis that GM3 is an important ganglioside and shows 
that the synthesis of GM3 is very closely regulated. 
The cytoskeletal inhibitors had little effect on the 
labeling of the neutral glycolipids. This supports the idea 
that neutral glycolipids are synthesized in the endoplasmic 
reticulum or in a pre-Golgi compartment and that there is a 
separation of the initial glycosphingolipid glycosylation site 
from that of higher glycosylations. Treatment of primary 
neurons with cobalt and A23187 also supports the hypothesis of 
distinct glycosylation sites 
Cobalt caused a significant reduction in labeling of 
the higher gangl iosides (GPX, GQ1b, and GT1b) in primary 
neurons (Figure 47b). The labeling of GM3 and GD3 remained 
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unchanged after cobalt treatment which again suggests the 
close regulation of these gangliosides. This data also 
suggests that higher glycosylation sites are distinct from 
intermediate glycosylation sites. One significant difference 
between cobalt treatment and monensin treatment was the 
enhancement of label into GM2 after cobalt treatment. Both 
GD3 and GM2 are the first step in the "b" series and in the 
"a" series after GM3 branches. There may be a distinct 
regulatory component which affects which pathway ganglioside 
anabolism will follow. Cobalt, which is thought to specif-
ically inhibit transport between the endoplasmic reticulum and 
the ci s face of the Gol gi, caused a 1 arge increase in the 
incorporation of label into glucosylceramide but a reduction 
of label into lactosylceramide. This data suggests that 
cobalt interferes at another earlier step of gangl ioside 
anabolism than does monensin. This provides further evidence 
for a distinct compartmentalization of glycosylation sites. 
When primary neurons are treated with the calcium 
ionophore A23187 there is an large inhibition of label into 
GPX, GQ1b, GT1b, and GD1a (Figure 49a and 49b). A23187 had no 
effect on the label incorporation into GM1, GM3, and GD1b. 
The incorporation of label into GD3 and GM3 was greatly 
increased by treatment with A23187. The increase in calcium 
levels and the corresponding increase in labeling of GD3 and 
GM2 after treatment with A23187 suggest a role for calcium in 
regulating which pathway GM3 wi 11 fol low. This data also 
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supports the idea of separate compartmentalization of neutral 
glycolipid and ganglioside anabolism. There was no apparent 
effect of A23187 on the incorporation of label into lactosyl-
ceramide or glucosylceramide (Table 8). 
SUMMAR)". 
The transport pathways of gangliosides in chick 
primary neuronal cultures were examined by perturbing these 
pathways with monensin, colchicine, vinblastine, cytochalasin 
D, cobalt, and A23187. Results from this study confirm that 
there is a distinct compartmentalization of earlier glyco-
sylation sites from later glycosylation sites in the ordered 
processing of gangliosides. Cobalt inhibits the earliest step 
in the biosynthetic pathway of gangliosides_because it caused 
a significant increase in labeling of glucosylceramide (Table 
7) while the other inhibitors had no effect. The synthesis of 
glucosylceramide may reside in the endoplasmic reticulum 
because cobalt is known to interfere with transport between 
the endoplasmic reticulum and the Golgi. There was a 
significant enhancement of label into lactosylceramide (Table 
4) after monensin and nigericin treatment but the other 
inhibitors had no effect. Lactosylceramide synthesis may be 
in an extra-Golgi compartment. When the Golgi is disrupted by 
monensin treatment the transport from this extra- Golgi 
compartment to the Golgi may be inhibited. 
There was no significant change in the labeling of GM3 
for any of the inhibitors studied. Synthesis of GM3 appears 
to be very closely regulated and might be synthesized in a 
rapid anabolic extra-Golgi compartment. There is no change in 
the labeling of GM3 yet there is an increase in the labeling 
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of lactosylceramide. 
1 1 7 
If monensin is stimulating lactosyl-
ceramide synthesis you might think that GM3 would be inhibited 
but this is not the case. One might speculate that two path-
ways may exist at the dynamic border between the endoplasmic 
reticulum and the Golgi. One pathway for ganglioside biosyn-
thesis might destine lactosylceramide to be delivered to the 
Go 1 g i wh i le the second pathway might be destined for the 
plasma membrane. Lactosylceramide may be required for ecto-
enzyme synthesis of gangliosides on th~ plasma membrane 
(Dreyfus §..t. u). Since there are two pathways for lactosyl-
ceramide to take it may be only one pathway that is signif-
icantly affected by monensin. The incorporation of label 
into higher gangliosides (GPX, GQ1b, GT1b, GD1b ,GD1a, and 
GD2) are inhibited by monensin yet there is no accumulation of 
label into GM3. This lack of change in GM3 caused by all the 
inhibitors studied may result from a high turnover of this 
ganglioside. Such a high turnover might suggest an important 
control point in ganglioside biosynthesis. It is also 
possible that GM3 synthesis is regulated at the plasma 
membrane surface and therefore these intracellular inhibitors 
would have little effect. The fact that GM3 remains in 
transformed cells while the higher gangliosides are lost also 
suggests that GM3 is important for the cell. 
Transport between this extra-Golgi compartment and 
the cis face of the Golgi may involve calcium regulation 
because the calcium ionophore A23187 causes an enhancement of 
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1 abe 1 into GD3 and GM2 which are both the next step in 
gang 1 i os i de synthesis after GM3. 
pathways following GM2 and GD3 
The gangl i os ides in the 
have greatly diminished 
labeling after treatment with A23187. This could have 
important implications in the control of gangl ioside 
anabolism. The cell might control ganglioside anabolism by 
altering calcium concentration in the local area of 
ganglioside biosynthesis. This study reveals for the first 
time a compartmentalization of key gangli9.side biosynthetic 
pathways and an ordered processing of ganglioside metabolism 
in the primary neuron. 
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